ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,701 followers.

RT @FrontOncology: New research: ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreat…

09 Feb 2024

Reply Repost Favourite

New research: ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition: Purpose Despite accumulating data regarding the genomic… https://t.c

09 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.